HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 21460324.
- Also identified by DOI 10.1093/cid/cir107 and PMC identifier 3070033.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Of 682 antiretroviral-naïve patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with ≥1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia.
Medical subject headings
- Anti-HIV Agents
- Drug Resistance, Viral
- HIV Infections
- HIV-1
- Mutation, Missense